Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Dolny Kubin – page 11

168 clinical trials in Dolny Kubin, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Dolny Kubin at a glance
168
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

168 trials in Dolny Kubin

Open in trial search

Asthma

Not recruiting

Study on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Lambda Fab Fragment Against Thymic Stromal Lymphopoietin
  • Sponsor:AstraZeneca AB

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Prostate cancer

Not recruiting

Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Medivation Inc.

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

Diabetic retinopathy+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BAY 3283142
  • Sponsor:Bayer AG

Diabetic retinal oedema+1

Not recruiting

Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Urticaria chronic+2

Not recruiting

Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Study on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH

Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Opthea Limited

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Dolny Kubin

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials targeting cardiovascular disease and exploring new therapies for reducing major adverse cardiovascular events. Studies focus on lipid management and prevention of heart-related complications.

  • Lipoprotein management
  • Atherosclerotic disease treatment
  • Cardiovascular risk reduction

Research aims to evaluate novel compounds for improving cardiovascular outcomes in high-risk patients.

02 Stroke Prevention Studies

Advanced research investigating treatments for ischemic stroke prevention, particularly focusing on patients who have experienced acute non-cardioembolic strokes or transient ischemic attacks.

  • Post-stroke care
  • Blood clot prevention
  • Mini-stroke management

Trials evaluate new anticoagulation approaches while maintaining optimal safety profiles.

03 Chronic Disease Management

Comprehensive studies addressing chronic kidney disease and associated conditions, with particular attention to combination therapies for improved patient outcomes.

  • Kidney function preservation
  • Blood pressure control
  • Musculoskeletal conditions

Including innovative research on rotator cuff tendinopathy and combination treatment approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.